 Participant population. Arm 2: 35 cocaine-abusing opioid-dependent outpatients. Arm 3: 50 cocaine-abusing opioid-dependent outpatients separate from those in Arm 2. Target enrollment for both arms will include 40 women and 60 minorities mostly African-American. 